The PREPARE Vaccines & Therapeutics Co-operative Strategic Grant, part of the Programme for Research in Epidemic Preparedness and Response (PREPARE) established by the Ministry of Health (MOH) Singapore, aims to enhance local expertise in managing vaccines and treatments for infectious diseases. Additionally, it focuses on streamlining the process from discovering potential vaccines and treatments to conducting clinical trials.
The research team should include a PI, at least one Co-Investigator (Co-I), and researchers from at least two local institutions. PIs must meet the following eligibility criteria:
- Hold a primary appointment in a locally publicly funded institution and receive salary from the institution.
- Possess a PhD or MD/MBBS/BDS qualification.
- Be an independent investigator, holding PI status within their institution, must showcase a proven research track record. This includes receiving nationally competitive funding and demonstrating a significant publication record over the past 3 years, with consideration given to international funding on an individual basis.
- Have a laboratory or clinical research program conducting research in Singapore.
- Maintain a minimum of 9 months of employment (per calendar year) with local Singapore institution(s). Upon receiving the award, the PI must commit to residing in Singapore for at least 6 months/calendar year for the duration of the grant.
- Have no outstanding reports from previous BMRC, NMRC grants, and other national grants.
For proposals involving patients, the PI should be registered with the Singapore Medical Council (SMC), or demonstrate the ability to access patients through SMC-registered Co-Is or collaborators.
The funding amount will be up to S$1.5M for the individual track or up to S$3M for the programmatic track. It will also cover indirect costs at 30%. The funding period will be for up to 2 years.
The next application is due on March 11, 2024.
March 11, 2024